• Thioredoxin Control of CHK1 Inhibitor Sensitivity

  2026-09-16

  This Nature Communications study identifies thioredoxin 1 as a determinant of CHK1 inhibitor sensitivity in non-small cell lung cancer and links that effect to redox control of ribonucleotide reductase and deoxynucleotide availability. The findings provide a mechanistic basis for combining CHK1 inhibition with thioredoxin reductase disruption, while also highlighting the need for biomarker-guided validation beyond single-model experiments.

• Sodium Orthovanadate in Cell Signaling Assays

  2026-09-15

  Learn how Sodium Orthovanadate (SKU A8524) can improve phosphorylation-state preservation when viability, proliferation, and cytotoxicity assays are paired with mechanistic signaling analysis. This scenario-based guide covers compatibility, preparation, interpretation, and practical vendor-selection criteria for Na3VO4 workflows.

• Octyl-α-ketoglutarate for HIF-1α Assays

  2026-09-15

  A scenario-based guide to using Octyl-α-ketoglutarate, SKU C4321, to separate metabolic effects from oxygen-dependent HIF-1α regulation in viability, proliferation, and cytotoxicity workflows. It covers experimental controls, handling, interpretation, and practical vendor-selection criteria.

• Azilsartan in Astrocyte–Microglia Research

  2026-09-14

  Azilsartan (TAK-536) extends selective AT1 receptor interrogation beyond blood-pressure models into mechanistic studies of microglia-conditioned astrocyte reactivity. This workflow translates a 2024 study into practical stock-preparation, treatment-design, readout, and troubleshooting decisions for neuroinflammation research.

• Angiotensin (1-7): Mechanism to Translation

  2026-09-14

  Angiotensin (1-7) is more than a counter-regulatory renin–angiotensin system peptide: it is a mechanistic probe for Mas receptor biology, fibrosis, inflammation, metabolism, neuroprotection, and emerging host–pathogen questions. This article connects pathway insight with practical experimental design and translational decision-making.

• 3-Methyladenine Workflows for Autophagy Research

  2026-09-13

  Use 3-Methyladenine to interrogate class III PI3K-dependent autophagy, nutrient-stress responses, and migration phenotypes with time-aware controls. This guide connects practical 3-MA workflows to emerging cuproptosis research while highlighting interpretation limits and troubleshooting strategies.

• Antibiotic Use and Resistance in Psychiatric Hospitals

  2026-09-12

  This retrospective study links antibacterial-drug utilization with bacterial resistance patterns in a psychiatric hospital during the 2022 epidemic. Its main contribution is the integration of hospital prescribing metrics, microbiological submission data, and susceptibility results to inform stewardship in a high-contact psychiatric-care setting.

• Magneto-Piezoelectric Scaffolds Target JAK2-STAT3

  2026-09-11

  This ACS Nano study develops a dual-responsive scaffold that combines magnetic biofilm disruption with ultrasound-triggered metabolic reprogramming of Icam1+ macrophages. Its central contribution is linking JAK2-STAT3 activation and MAPK-JNK suppression to oxidative phosphorylation, pro-reparative immune activity, and improved regeneration of infectious bone defects.

• Z-VDVAD-FMK: Apoptosis Pathway Mapping

  2026-09-11

  Z-VDVAD-FMK helps researchers distinguish caspase-2-linked mitochondrial apoptosis from downstream caspase-3/7 activity and caspase-independent death. This workflow also shows how to use it as a mechanistic control when studying HOXC8-associated pyroptosis in lung cancer models.

• Bedaquiline: An Energy-Centered Assay Framework

  2026-09-10

  Bedaquiline is a diarylquinoline antibiotic whose energy-targeting mechanism supports a rigorous framework for tuberculosis and cancer-metabolism research. This article distinguishes direct bacterial ATP-synthase inhibition from host-directed GSK3 biology and translates both into practical assay decisions.

• Haloprogin: Evidence from a Foundational Antifungal Study

  2026-09-10

  The 1970 study by Harrison and colleagues established Haloprogin as a topical antifungal with dermatophyte activity comparable to tolnaftate, while also demonstrating activity against Candida species and selected Gram-positive bacteria. Its combination of serial-dilution testing, fungicidal endpoints, and steroid-maintained guinea pig infection models provides a useful framework for interpreting spectrum, formulation, and translational limitations.

• Morin: A Mechanism-First Neuroinflammation Probe

  2026-09-09

  Morin is a natural flavonoid antioxidant with applications spanning oxidative-stress biology, mitochondrial metabolism, and fluorescent aluminum detection. This article presents a phenotype-first framework for using Morin in neurological and metabolic disease assays without confusing preclinical mechanism with clinical treatment.

• LG 101506 (RXR modulator) in Cell Assays

  2026-09-09

  A scenario-based guide to using LG 101506 (RXR modulator), SKU B7414, in cell viability, proliferation, and cytotoxicity workflows. It covers formulation controls, protocol design, interpretation, and evidence boundaries for RXR signaling pathway research.

• LY2603618: A Biomarker-Led Chk1 Assay Strategy

  2026-09-08

  LY2603618 is a selective Chk1 inhibitor for investigating replication stress, checkpoint dependence, and chemotherapy sensitization. This article develops a biomarker-led assay framework based on PPP2R2A biology, helping researchers distinguish genuine Chk1 dependency from nonspecific DNA damage.

• miR-3180 Rewires Lipid Metabolism in HCC

  2026-09-08

  Hong et al. show that miR-3180 suppresses hepatocellular carcinoma by simultaneously limiting SCD1-dependent fatty acid synthesis and CD36-mediated lipid uptake. The study combines patient-tissue analysis, mechanistic reporter assays, functional cancer-cell experiments, lipid measurements, and xenograft validation to connect one microRNA with two complementary metabolic inputs.

8125 records 3/542 page Previous Next 12345 下5页 Last page